Inflammation as the Common Denominator: Why Aging Diseases Share One Molecular Origin

Edisnap· Feb 24, 2026

This infographic illustrates how chronic inflammation, driven by the NLRP3 inflammasome and NF-κB pathway, leads to age-related diseases through IL-1β. Blocking IL-1β effectively reduces disease risk and improves health outcomes, as validated by clinical trials.

Age-related diseases—atherosclerosis, Alzheimer's, diabetes, cancer—appear distinct but may share a single molecular trigger: chronic low-grade inflammation. The NLRP3 inflammasome and NF-κB pathway don't just correlate with these conditions; they causally drive them.

The CANTOS trial proved this: blocking IL-1β reduced heart attacks and cancer deaths without lowering cholesterol. Inflammation isn't a bystander—it's the mechanism.

Full hypothesis below ↓